Results 341 to 350 of about 3,504,577 (381)

Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation.

New England Journal of Medicine, 2023
BACKGROUND The role of catheter ablation in patients with symptomatic atrial fibrillation and end-stage heart failure is unknown. METHODS We conducted a single-center, open-label trial in Germany that involved patients with symptomatic atrial ...
C. Sohns, H. Fox, N. Marrouche, H. Crijns, A. Costard-Jaeckle, L. Bergau, G. Hindricks, N. Dagres, Samuel T. Sossalla, R. Schramm, T. Fink, M. El Hamriti, M. Moersdorf, V. Sciacca, Frank Konietschke, V. Rudolph, J. Gummert, J. Tijssen, P. Sommer   +18 more
semanticscholar   +1 more source

Atrial Fibrillation Catheter Ablation vs Medical Therapy and Psychological Distress: A Randomized Clinical Trial.

Journal of the American Medical Association (JAMA), 2023
Importance The impact of atrial fibrillation (AF) catheter ablation on mental health outcomes is not well understood. Objective To determine whether AF catheter ablation is associated with greater improvements in markers of psychological distress ...
A. Al-Kaisey, R. Parameswaran, Christina Bryant, Robert D. Anderson, Joshua Hawson, D. Chieng, L. Segan, A. Voskoboinik, H. Sugumar, Geoffrey R. Wong, S. Finch, S. Joseph, A. Mclellan, L. Ling, J. Morton, P. Sparks, Prashanthan Sanders, Geoffrey Lee, P. Kistler, J. Kalman   +19 more
semanticscholar   +1 more source

Coronary Artery Spasm During Pulsed Field vs Radiofrequency Catheter Ablation of the Mitral Isthmus.

JAMA cardiology, 2023
Importance In treating atrial fibrillation, pulsed field ablation (PFA) is a novel energy modality with comparable efficacy to conventional thermal ablation, such as radiofrequency ablation (RFA), but with the benefit of some preferentiality to ...
Chi Zhang, P. Neužil, J. Petrů, Moritoshi Funasako, P. Hála, Karel Kopriva, Jacob S. Koruth, S. Dukkipati, Vivek Y. Reddy   +8 more
semanticscholar   +1 more source

Catheter Ablation of Ventricular Arrhythmias

New England Journal of Medicine, 2019
Catheter Ablation of Ventricular Arrhythmias Catheter ablation of ventricular tachycardia involves identifying the mechanism (a focus with abnormal impulse formation or a reentrant circuit), mappin...
K. Shivkumar
openaire   +3 more sources

Efficacy of LGE‐MRI‐guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation: The DECAAF II trial: Study design

Cardiovascular Electrophysiology, 2021
Success rates of catheter ablation in persistent atrial fibrillation (AF) remain suboptimal. A better and more targeted ablation strategy is urgently needed to optimize outcomes of AF treatment.
N. Marrouche, T. Greene, J. M. Dean, E. Kholmovski, Leonie Morrison‐de Boer, M. Mansour, H. Calkins, F. Marchlinski, D. Wilber, G. Hindricks, C. Mahnkopf, P. Jais, P. Sanders, J. Brachmann, J. Bax, Lilas Dagher, O. Wazni, N. Akoum   +17 more
semanticscholar   +1 more source

Catheter ablation

Current Opinion in Cardiology, 1991
Catheter ablation is gaining increasing interest for the therapy of symptomatic, sustained arrhythmias of various origins. The scope of this review is to give an overview of the biophysical aspects and major characteristics of some of the most widely used energy sources in catheter ablation, e.g., the discharge of conventional defibrillators, modified
M, Fromer, M, Shenasa
openaire   +2 more sources

Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data.

European Heart Journal, 2020
AIMS The optimal treatment for patients with atrial fibrillation (AF) and heart failure (HF) has been a subject of debate for years. We aimed to evaluate the efficacy and safety of rhythm control strategy in patients with AF complicated with HF regarding
Shaojie Chen, H. Pürerfellner, C. Meyer, W. Acou, A. Schratter, Zhiyu Ling, Shaowen Liu, Yuehui Yin, M. Martinek, M. G. Kiuchi, B. Schmidt, K. Chun   +11 more
semanticscholar   +1 more source

Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia.

New England Journal of Medicine
BACKGROUND Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular tachycardia.
J. Sapp, Anthony S L Tang, R. Parkash, William G. Stevenson, J. Healey, L. Gula, Girish M. Nair, V. Essebag, Léna Rivard, J. Roux, P. Nery, J. Sarrazin, Guy Amit, J. Raymond, M. Deyell, Chris Lane, Frédéric Sacher, C. de Chillou, Vikas Kuriachan, A. AbdelWahab, Isabelle Nault, Katia Dyrda, Stephen Wilton, U. Jolly, Arvindh N. Kanagasundram, George A. Wells   +25 more
semanticscholar   +1 more source

Impact of atrial fibrillation catheter ablation on mortality, stroke, and heart failure hospitalizations: A meta‐analysis

Cardiovascular Electrophysiology, 2020
The impact of atrial fibrillation catheter ablation (AFCA) on hard clinical endpoints remains controversial.
A. Saglietto, R. De Ponti, L. Di Biase, M. Matta, F. Gaita, Jorge Romero, G. D. de Ferrari, M. Anselmino   +7 more
semanticscholar   +1 more source